Related references
Note: Only part of the references are listed.Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2
Kazuaki Takabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples
Zhenwen Zhao et al.
JOURNAL OF LIPID RESEARCH (2010)
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis
C. E. Holmes et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis
C. A. C. Hyde et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Lysophosphatidic Acid in Vascular Development and Disease
Siew T. Teo et al.
IUBMB LIFE (2009)
Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes
Naoki Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine
Zhenwen Zhao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice
Hui Li et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis
Mandi M. Murph et al.
PLOS ONE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Age-related changes in bone morphology are accelerated in group VIA phospholipase A(2) (iPLA(2)beta)-null mice
Sasanka Ramanadham et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Two pathways for lysophosphatidic acid production
Junken Aoki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner
Orlando D. Gil et al.
GYNECOLOGIC ONCOLOGY (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells
Dongmei Wang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells
Yuanda Song et al.
BIOCHEMICAL JOURNAL (2007)
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion
S. Sengupta et al.
ONCOGENE (2007)
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1
Gerald Schmid et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells
Xiaoxian Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo
Kwan-Sik Kim et al.
CANCER RESEARCH (2006)
Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis
Shunzhong Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells
J Ren et al.
CANCER RESEARCH (2006)
Lysophosphatidic acid is a major regulator of growth-regulated oncogene α in ovarian cancer.
Z Lee et al.
CANCER RESEARCH (2006)
Effects of stable suppression of group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells
SZ Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Genetic and pharmacologic evidence that calcium-independent phospholipase A2β regulates virus-induced inducible nitric-oxide synthase expression by macrophages
JM Moran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappa B pathway by lysophosphatidic acid, an ovarian cancer-activating factor
CH Chou et al.
CARCINOGENESIS (2005)
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells
XJ Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
β-cell calcium-independent group VIA phospholipase A2 (iPLA2β) -: Tracking iPLA2β movements in response to stimulation with insulin secretagogues in INS-1 cells
SZ Bao et al.
DIABETES (2004)
Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility
SZ Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
A Boucharaba et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Biology of LPA in health and disease
S Sengupta et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
A novel laminin-induced lysophosphatidic acid autocrine loop in the migration of ovarian
S Sengupta et al.
FASEB JOURNAL (2003)
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
A Tokumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Phospholipase A2 enzymes
I Kudo et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
M Umezu-Goto et al.
JOURNAL OF CELL BIOLOGY (2002)
Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids
YJ Xiao et al.
ANALYTICAL BIOCHEMISTRY (2001)
Share Paper
